Patent ID: 6458842
Filing Date: 2002-10-01
Classification: A61K,Y10S

Abstract:
A stable liquid oral dosage pharmaceutical composition, said composition comprising at least one thyroid hormone selected from the group consisting of L-3,5,3â€²,5â€²-tetraiodothyronine (levothyroxine or LT4), L-3,5,3â€²-triiodothyronine (liothyronine or LT3), L-3,3â€²,5â€²-triiodothyronine (LrT3), L-3,5-diiodothyrone (LT2), pharmaceutically acceptable salts thereof, and mixtures thereof; from about 40% to about 96% of ethanol by volume; a pH adjusting agent so that the measured pH of the composition is from about 9 to about 12; and from about 4% to about 50% water by volume.